Core Viewpoint - MDJM LTD has announced the pricing of an upsized public offering of 4,280,000 units at a price of $1.40 per unit, aiming to raise approximately $6.0 million in gross proceeds before expenses [1] Group 1: Offering Details - Each unit in the offering consists of one Class A ordinary share and one Series A warrant to purchase one Class A ordinary share [1] - The Series A warrants will expire one year from issuance and are immediately exercisable at an initial price equal to the public offering price, with adjustments on the fourth and eighth trading days [1] - The underwriters have a 45-day option to purchase up to an additional 642,000 Class A ordinary shares and/or Series A warrants [1] Group 2: Company Background - MDJM LTD is an integrated global culture innovation company focused on cultural IP development, animation production, international licensing, and cultural venue operations [1] - The company is expanding its operations in the UK, with projects like Fernie Castle and the Robin Hill Property being remodeled into multifunctional cultural venues [1] - MDJM is collaborating with European animation studios to develop animated short films that blend Eastern themes with Western artistry, aiming to create a global cultural ecosystem [1]

Core Viewpoint - Ascent Solar Technologies (ASTI) has entered into definitive agreements for a private placement of common stock and warrants, aiming to raise approximately $10 million in gross proceeds, with potential additional proceeds of $15 million if warrants are fully exercised [1]. Group 1: Private Placement Details - The company will sell a total of 1,818,182 shares of common stock and associated warrants at a price of $5.50 per share [1]. - The series A warrants will allow the purchase of up to 1,818,182 shares, while the short-term series B warrants will allow the purchase of up to 909,091 shares, both with an exercise price of $5.50 [1]. - The private placement is expected to close around January 26, subject to customary closing conditions [1]. Group 2: Warrant Expiration and Proceeds - The series A warrants will expire five years from the effective date of the Resale Registration Statement, while the short-term series B warrants will expire eighteen months from the same date [1]. - The gross proceeds from the offering are expected to be approximately $10 million before deducting fees and expenses [1]. - If the series A and short-term series B warrants are fully exercised on a cash basis, the company could receive an additional gross proceeds of approximately $15 million [1].

Core Points - Opendoor Technologies Inc. announced the distribution of warrants to purchase common stock to registered stockholders and certain convertible noteholders on November 21, 2025, as part of a special dividend [1][2] - Each stockholder of record as of November 18, 2025, received three series of warrants (Series K, Series A, and Series Z) at a ratio of one warrant per thirty shares held [1][3] - The CEO emphasized that this warrant dividend reflects confidence in the company's business and aims to strengthen the relationship with shareholders [2] Warrant Terms - Eligibility for receiving warrants is based on being a shareholder of record as of the Record Date, November 18, 2025 [3] - The distribution ratio is one warrant of each series for every thirty shares held, with no fractional warrants issued [3] - Exercise prices are set at $9.00 for Series K, $13.00 for Series A, and $17.00 for Series Z [3] - The warrants are exercisable for cash, with a potential for net exercise as per the warrant agreement [3] - Each series of warrants will expire on November 20, 2026, unless the Early Expiration Price Condition is met [3] - The Early Expiration Price Condition requires the daily volume-weighted average price of the common stock to meet or exceed specified trigger prices for each series [3] Additional Information - Shareholders are encouraged to review the company's Investor Relations Resource Page for more information [4] - The warrants are expected to trade on Nasdaq under the tickers OPENW (Series K), OPENL (Series A), and OPENZ (Series Z) [7] - Convertible noteholders of the 7.000% Convertible Senior Notes due 2030 received warrants on the same terms as common stockholders [7]

Core Points - Salarius Pharmaceuticals Inc. shares increased by 23.65% in after-hours trading, closing at $1.21, following the announcement of pricing details for its public offering [1] - The stock had previously dropped 51% during regular trading, closing at $0.98 [1] Offering Details - Salarius announced a public offering aimed at raising approximately $7 million in gross proceeds before fees [2] - The offering includes 2.51 million common stock shares and pre-funded warrants for 2.15 million shares, priced at $1.50 per share [2] Warrant Structure and Terms - The exercise price for both Series A and Series B warrants is set at $1.50 [3] - Series B warrants have a one-year exercise window, while Series A warrants can be exercised for five years after issuance [3] - The warrants feature fixed pricing with no variable pricing elements [3] Merger-Contingent Closing - The closing of the offering is contingent upon the completion of Salarius' proposed business combination with Decoy Therapeutics Inc., expected to occur on Wednesday [4] - Ladenburg Thalmann & Co. Inc. is the sole book-running manager for the offering [4] - Proceeds from the offering will be used to fund research programs, repay Decoy's promissory notes, and cover working capital needs [4] Stock Performance - Year-to-date, Salarius' stock has decreased by 96.25% [5] - The company has a market capitalization of $1.03 million and an average daily trading volume of 318,090 shares [5] - Benzinga Edge Stock Rankings indicate a negative price trend for SLRX across all time frames [5]

Core Points - Opendoor Technologies Inc. announced a special dividend distribution of warrants to common stockholders as of November 18, 2025, aiming to align management's performance with shareholder benefits [1][2][3] Warrant Distribution Details - The warrants will be distributed on or about November 21, 2025, without any action or payment required from stockholders [4] - Each shareholder will receive three series of warrants (Series K, A, and Z) at a ratio of one warrant per thirty shares held, rounded down [5][6] - The exercise prices for the warrants are set at $9.00 for Series K, $13.00 for Series A, and $17.00 for Series Z, with an expiration date of November 20, 2026 [5][12] Trading and Liquidity - The warrants are expected to be listed on Nasdaq under the tickers OPENW, OPENL, and OPENZ, allowing immediate trading or holding for potential upside [6][12] - The structure of the warrants is designed to be non-dilutive at issuance, protecting current shareholders while enabling upside participation [6][12] Alignment with Shareholders - The program is intended to rebuild trust and ensure that if management succeeds, shareholders benefit directly, emphasizing a structural alignment rather than a theoretical one [2][3] - An investor FAQ will be available to address questions regarding the mechanics of the warrant distribution [9]